For citations:
Sultanbaev A.V., Fatyhov R.I., Gladkov O.A., Dvorkin M.V., Solovieva E.P., Cheporov S.V., Loleit A.S., Ruzavina E.I. Pharmacotherapy regimens for patients with hormone-receptor positive (HR+), human epidermal growth factor 2 negative (HER2–) metastatic breast cancer in routine clinical practice (results of non-interventional retrospective study). Medical alphabet. 2022;(31):7-14. (In Russ.) https://doi.org/10.33667/2078-5631-2022-31-7-14
Email this article 